Important note

This AI stock analysis for Shattuck Labs is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Shattuck Labs - AI Stock Analysis

Analysis generated July 24, 2024

Shattuck Labs is a clinical-stage biotechnology company focused on developing innovative treatments for cancer and other serious diseases. The company leverages its unique Agonist Redirected Checkpoint (ARC) platform to create therapies that simultaneously stimulate immune responses while blocking checkpoint pathways that limit immune activity. This dual mechanism aims to overcome the challenges faced by existing immunotherapies.

Fundamental Analysis

Revenue for Shattuck Labs in the last quarter was $1.1 million, representing an impressive 56.16% increase compared to the preceding quarter. Compared to the same quarter last year, revenue has surged by a remarkable 1,856.14%, indicating robust year-over-year growth and suggesting effective product commercialization or successful partnerships.

Net income for the last quarter was $19 million, showing a decrease of 4.62% compared to the previous quarter. Although this decrease calls for concern, the year-over-year growth stands at 10.71%, reflecting overall positive financial performance. EBITDA for the last quarter was also $19 million, a decrease of 6.12% from the prior quarter, but a 7.64% year-on-year increase, signaling improved operational efficiency over the past year despite recent quarterly performance dips.

Technical Analysis

Shattuck Labs' current stock price is $4.40, an 11.11% increase compared to a month ago, indicating a positive short-term price trend. On a longer horizon, the stock price has appreciated by 68.58% over the past year, confirming a bullish sentiment. The SMA10 is currently at 4.54 compared to the previous SMA10 of 4.52; this suggests a potential upward trend in price movement. The RSI (Relative Strength Index) is 47.4, indicating a neutral market condition, suggesting neither overbought nor oversold status.

Alternative Data Analysis

In terms of job postings and employee sentiment, Shattuck Labs has 2 open positions, reflecting a 100% increase over recent months. This implies a company gearing up for expansion and growth, which is a healthy signal. In terms of customer acquisition, the company has an estimated 7,000 visitors to its webpage with no significant changes in the past few months. This stability in digital audience may indicate ongoing interest without substantial marketing changes.

Furthermore, AltIndex’s AI score for Shattuck Labs stands at 70, which indicates a 'Buy' signal. This score combines fundamental, technical, and alternative data analysis to make a comprehensive stock prediction.

Conclusion and Recommendation

Based on the data analyzed, Shattuck Labs shows signs of growth both fundamentally and technically. The significant year-over-year increases in revenue, net income, and EBITDA reflect strong performance, although the recent quarterly declines warrant careful monitoring. The bullish trend in stock price corroborates positive investor sentiment.

Alternative data points, such as increased job postings and promising AI score of 70, further substantiate the potential for future growth.

Given the combination of robust fundamental performance, bullish technical indicators, and positive alternative data signals, it would be reasonable to consider Shattuck Labs as a 'Buy'. However, the slight quarterly dips in net income and EBITDA should be closely watched in future quarters to ensure continued growth and operational efficiency.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.